Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Kineta Cuts Deal With MPI
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1)
|
Luke Timmerman |
09/23/09 |
Seattle
|
|
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO
|
Luke Timmerman |
09/18/09 |
Seattle
|
|
Zymo Drug Fails Arthritis Trials
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets
|
Luke Timmerman |
08/18/09 |
San Diego
|
|
Avila Therapeutics Gets $30M to Push Ahead With Covalent Drugs
|
Luke Timmerman |
07/27/09 |
Boston
|
|
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/23/09 |
Seattle
|
|
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug
|
Luke Timmerman |
07/21/09 |
Seattle
|
|
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/09/09 |
Seattle
|
|
Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy
|
Luke Timmerman |
07/08/09 |
Seattle
|
|
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Taligen Raises $26M For Inflammation Drugs
|
Luke Timmerman |
05/12/09 |
Boston
|
|
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash
|
Luke Timmerman |
04/29/09 |
Seattle
|
|
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union
|
Luke Timmerman |
04/06/09 |
Seattle
|
|
Trubion Starts Lupus Trial
|
Luke Timmerman |
03/25/09 |
Seattle
|
|
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys
|
Luke Timmerman |
03/11/09 |
Boston
|
|
Dicerna Aims to Gain Foothold in RNAi World With More Potent, Longer-Lasting Gene Silencers
|
Luke Timmerman |
01/30/09 |
Boston
|
|
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/29/09 |
Seattle
|
|
ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate
|
Luke Timmerman |
01/28/09 |
Seattle
|
|
Riding the Diabetes Wave, Novo Nordisk Sees Chance to Scoop Up Biotech Talent in Seattle
|
Luke Timmerman |
01/28/09 |
Seattle
|
|
Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs
|
Luke Timmerman |
01/27/09 |
Seattle
|
|
Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders
|
Luke Timmerman |
01/27/09 |
San Diego
|
|
Archemix Secures Partnership with Glaxo to Develop Drugs for Inflammatory Diseases
|
Luke Timmerman |
12/23/08 |
Boston
|
|
KaloBios Gets $12M Genzyme, Baxter
|
Luke Timmerman |
12/22/08 |
Boston
|
|
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/18/08 |
Seattle
|
|
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity
|
Luke Timmerman |
12/17/08 |
Seattle
|
|
Seattle Genetics Drug Fights Hodgkin’s, Frazier Sounds Off on Biotech Ventures, SBRI Pushes Malaria Vaccine, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/11/08 |
Seattle
|
|
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher
|
Luke Timmerman |
10/08/08 |
Seattle
|
|
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA
|
Luke Timmerman |
09/03/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
